Mitchell Chupak
Directeur/Membre du Conseil chez KAYA HOLDINGS, INC.
Fortune : 13 673 $ au 30/04/2024
Provenance du réseau au premier degré de Mitchell Chupak
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Agricultural Commodities/Milling | 5 | |
The Institute for the Advancement of Education in Jaffa
3
| Non-Profit Organization | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mitchell Chupak via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| WINTHROP REALTY TRUST | Real Estate Investment Trusts | Chief Executive Officer | |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Pharmaceuticals: Major | Director/Board Member | |
| Regent University | College/University | Masters Business Admin | |
| HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD | Multi-Line Insurance | Director/Board Member | |
| MIGDAL INSURANCE AND FINANCIAL HOLDINGS LTD. | Multi-Line Insurance | Director/Board Member | |
| ISRAEL DISCOUNT BANK LIMITED | Major Banks | Director/Board Member | |
| PRIORTECH LTD | Industrial Machinery | Director/Board Member | |
| ALONY-HETZ PROPERTIES & INVESTMENTS LTD | Real Estate Development | Director/Board Member | |
| DROR ORTHO-DESIGN, INC. | Computer Peripherals | Chairman | |
| John Brown University | College/University | Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Chairman | |
| The Hebrew University of Jerusalem | College/University | Masters Business Admin | |
Banco Industrial SA
 Banco Industrial SA Major BanksFinance Banco Industrial SA provides commercial banking services. The firm's services include loans, depository accounts and related services. The company was founded on June 15, 1967 and is headquartered in Bainsa, Guatemala. | Major Banks | Corporate Officer/Principal | |
| Northwell Health Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
Teva Pharmaceuticals Europe BV
 Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The company is based in Haarlem, Netherlands. | Miscellaneous | Chief Executive Officer | |
The Tel Aviv Stock Exchange (Investment Management)
 The Tel Aviv Stock Exchange (Investment Management) Investment Banks/BrokersFinance Part of The Tel Aviv Stock Exchange Ltd., The Tel Aviv Stock Exchange (Investment Management) is a company that provides fund management services. The company is based in Tel Aviv, Israel. Ittai Ben Zeev has been the CEO of the Israeli company since 2017. | Investment Banks/Brokers | Director/Board Member | |
| Galmed Medical Research Ltd. | Director/Board Member | ||
| POLYPID LTD. | Pharmaceuticals: Major | Chairman | |
Plurality Ltd.
 Plurality Ltd. SemiconductorsElectronic Technology Plurality Ltd. develops multicore processing solutions. Its products include intellectual property licenses, hypercore based chips, development tools and acceleration boards. The firm offers comprehensive hardware and software solutions that simplify the task of migrating from serial processing to manycore processing. The company was founded in 2004 by Peleg Aviely, Ran Ginosar and Nimrod Bayer and is headquartered in Netanya, Israel. | Semiconductors | Director/Board Member | |
Dynamic Health Laboratories, Inc.
 Dynamic Health Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Dynamic Health Laboratories, Inc. manufactures organic and natural liquid nutritional products. Its products include African Bush Mango Juice Blend, African Bush Mango with Irvingia IGOB131 and Green Coffee Bean Complete. The company was founded in 1994 and is headquartered in Brooklyn, NY. | Pharmaceuticals: Other | Chief Executive Officer | |
| First Diversity Management Group | Director/Board Member | ||
| Discount Trust Ltd. | Chairman | ||
Israel Diamond Manufacturers Association Ltd.
 Israel Diamond Manufacturers Association Ltd. Miscellaneous Commercial ServicesCommercial Services Israel Diamond Manufacturers Association Ltd. engages in the advancement of the diamonds industry and the unification of diamonds producers. The company was founded in 1940 and is headquartered in Ramat Gan, Israel. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| John Jay College of Criminal Justice | College/University | Undergraduate Degree | |
| Hadas Arazim Group Ltd. | President | ||
| Discount Provident Funds Management Ltd. | Chief Executive Officer | ||
| ENERGIX - RENEWABLE ENERGIES LTD. | Alternative Power Generation | Director/Board Member | |
| Sapir Academic College | College/University | Director/Board Member | |
Cell Therapy Ltd.
 Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Director/Board Member | |
Genoscience Pharma
 Genoscience Pharma BiotechnologyHealth Technology Genoscience Pharma is a French clinical-stage biotechnology company that develops novel lysosomotropic therapeutics to establish a new standard of care against cancer, autoimmune, and infectious diseases. The private company is based in Marseille, France and was founded in 2001 by Philippe Halfon. Its lead candidate, GNS561, is a phase 2 ready drug candidate that tackles cancer cells through autophagy modulation. Genoscience Pharma is also entering a phase 2 trial with GNS561. | Biotechnology | Director/Board Member | |
| Shirat Hachaim Ltd. | Chairman | ||
Emerald Medical Applications Ltd.
 Emerald Medical Applications Ltd. Medical SpecialtiesHealth Technology Emerald Medical Applications Ltd. was engaged in the provision of medical apparatus software solutions. The company was founded by Adi Zamir and Lior Wayn on February 17, 2010 and was headquartered in Modi'in-Maccabim-Re'ut, Israel. | Medical Specialties | Director/Board Member | |
| Jerusalem School of Business Administration | College/University | Masters Business Admin | |
| VIEWBIX INC. | Computer Peripherals | Director/Board Member | |
NeuroRx, Inc.
 NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Biotechnology | Director/Board Member | |
| Latin American Financial Services, Inc. | Corporate Officer/Principal | ||
Celixir Plc
 Celixir Plc Pharmaceuticals: MajorHealth Technology Celixir Plc discovers and develops regenerative medicines to treat life threatening and life altering diseases. It offers heartcel-immunomodulatory progenitor imp cells, tendoncel-platelet lysate based therapy, myocardion-progenitor cells of mesodermal lineage. The company was founded by Martin Evans and Ajan Reginald in 2009 and is headquartered in Stratford-upon-Avon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
MyBiotics Pharma Ltd.
 MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member | |
| Pension Plan of El Al Israel Airlines Ltd. | Director/Board Member | ||
| Rom Fund | Investment Trusts/Mutual Funds | Director/Board Member | |
| Aerodentis | Chairman | ||
| MRRThirteen Ltd. | Miscellaneous | Director/Board Member | |
| SUFRIN HOLDINGS LTD. | Real Estate Development | Director/Board Member | |
Forma Real Estate Funds
 Forma Real Estate Funds Investment Trusts/Mutual FundsMiscellaneous Forma Real Estate Funds operates as a closed-end investment fund. The private company is based in Tel Aviv, Israel. The Israeli company was founded by Linda Ben Shoshan. | Investment Trusts/Mutual Funds | Founder | |
| Aluminum Construction Pro Ltd. | Chief Executive Officer | ||
| NRX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Dror Ortho-Design Ltd.
 Dror Ortho-Design Ltd. Medical/Nursing ServicesHealth Services Part of Novint Technologies, Inc., Dror Ortho-Design Ltd. provides dental services. The company is based in Jerusalem, Israel. Eliyahu Haddad has been the CEO of the Israeli company since 2021. Dror Ortho-Design was acquired by Novint Technologies, Inc. on August 21, 2023. | Medical/Nursing Services | Chairman |
Statistiques
Internationale
| Israël | 31 |
| Etats-Unis | 14 |
| Royaume-Uni | 3 |
| Guatemala | 2 |
| Pays-Bas | 2 |
Sectorielle
| Health Technology | 12 |
| Finance | 10 |
| Consumer Services | 8 |
| Miscellaneous | 6 |
| Electronic Technology | 4 |
Opérationnelle
| Director/Board Member | 51 |
| Chairman | 20 |
| Chief Executive Officer | 16 |
| Independent Dir/Board Member | 16 |
| President | 13 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michael L. Ashner | 28 |
| Chaim Hurvitz | 25 |
| Linda Ben Shoshan | 22 |
| Carrie Schwarz | 9 |
| Craig Frank | 7 |
| Jordi Arimany | 6 |
| David A. Levine | 3 |
| Bruce R. Burwick | 2 |
- Bourse
- Insiders
- Mitchell Chupak
- Connexions Sociétés
